Search / Trial NCT06231914

Efficacy and Safety of Fractional 1064-nm Picosecond Laser for Facial Skin Tightening

Launched by MAHIDOL UNIVERSITY · Jan 21, 2024

Trial Information

Current as of October 07, 2024

Recruiting

Keywords

Description

The efficacy and safety of fractional 1064-nm picosecond laser for facial skin tightening in participants aged 40 to 55 years, BMI \< 25 kg/m2, and have mild to moderate facial laxity.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Aged 40-55 years
  • * BMI \< 25 kg/m2
  • * Asian
  • * Mild to moderate facial skin laxity using quantitative grading scale (grade 1.5-2.5)
  • Exclusion Criteria:
  • * Pregnant or lactation
  • * Subjects who have been treated with any kind of energy-based device 6 months prior to the inclusion
  • * Subjects who have been injected with botulinum toxin, filler, or platelet-rich plasma on their faces 6 months prior to the inclusion
  • * Active skin infections
  • * History of hypertrophic scars or keloids

About Mahidol University

Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.

Locations

Bangkok, , Thailand

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0